New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareProstamax vs Sermorelin

Prostamax vs Sermorelin

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Prostamax
Growth Hormone PeptidesAnti-Aging & Longevity
Sermorelin
Summary
Prostamax is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) developed by Professor Vladimir Khavinson, tissue-specific for the prostate gland. It supports prostate epithelial cell function, promotes normalization of prostate tissue, and is studied for its potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate anti-aging. It is one of the more widely used Khavinson bioregulators among men over 40.
Sermorelin is a bioidentical synthetic peptide comprising the first 29 amino acids of naturally occurring GHRH. It is FDA-approved for diagnostic use and widely prescribed off-label for anti-aging, stimulating growth hormone production in a natural pulsatile pattern that mimics the body's own rhythm.
Half-Life
Short (minutes); sustained gene-regulatory effects
10–20 minutes
Admin Route
SubQ, Oral
SubQ
Research
Typical Dose
10 mg per day
200–500 mcg
Frequency
Daily for 10–30 days
5–7 days per week
Key Benefits
  • Supports normalization of prostate tissue architecture
  • May reduce prostate enlargement associated with BPH
  • Anti-inflammatory effects on prostatic tissue
  • Reduces prostate cell apoptosis from oxidative stress
  • Potential support in chronic prostatitis
  • Anti-aging effects on prostate glandular tissue
  • Complementary to conventional BPH therapies
  • Increases energy and vitality
  • Improves body composition (more muscle, less fat)
  • Enhances skin thickness and elasticity
  • Strengthens immune system
  • Improves sleep quality and REM sleep
  • Supports bone density
  • Enhances mental clarity and focus
  • Safer than exogenous HGH — respects natural feedback loops
  • FDA-approved for GH diagnostic use
Side Effects
  • Generally well tolerated in available research
  • Mild injection site reactions
  • No significant adverse urological events reported at standard doses
  • Injection site irritation
  • Flushing
  • Headache
  • Dizziness
  • +2 more
Stacks With